A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Certiva Overdose, Contraindications and Information - Certiva
Certiva Overdose, Contraindications and Information - Certiva
OVERDOSE
No information provided.
CONTRAINDICATIONS
Hypersensitivity to any component
of the vaccine, including
thimerosal (a mercury
derivative), is a contraindication
(See DESCRIPTION
).
It is a contraindication
to use this vaccine
after an immediate
anaphylactic reaction temporally associated with a previous dose.
Because of uncertainty as to which component
of the vaccine might
be responsible, no further
vaccination with any diphtheria, tetanus
or pertussis component
should be carried out. Alternatively, because of the importance
of tetanus vaccinations,
such individuals may be referred for evaluation
by an allergist. 3
The decision to administer or delay vaccination
because of a current or recent febrile
illness depends largely
on the severity of the symptoms and their etiology. Although a moderate
or severe febrile illness
is sufficient reason to postpone vaccinations, minor
illnesses such as mild
upper-respiratory infections with or without low-grade fever
are not contraindications. 3, 19, 20, 21, 22 Elective
immunization procedures
should be deferred during an outbreak
of poliomyelitis. 23 Data on the use of CertivaTM
in children for whom whole-cell pertussis
vaccine is contraindicated
are not available. Until such
data are available, it would be prudent to consider CDC Advisory
Committee on Immunization Practices (ACIP) and American Academy
of Pediatrics (AAP) contraindications to pertussis-containing vaccines
as contraindications to CertivaTM. 3, 20, 21
The ACIP states that "if
either of the following events occurs after administration
of DTaP or whole-cell D.P.
subsequent vaccination with DTaP or whole-cell DTP is contraindicated"22:
- An immediate anaphylactic
reaction.
- Encephalopathy not attributable to another identifiable cause
(e.g., an acute, severe
central nervous
system disorder
occurring within 7 days after vaccination
and generally consisting of major alterations in consciousness,
unresponsiveness, or generalized or focal
seizures that persist more than a few hours, without recovery
within 24 hours). In such
cases, DT vaccine should be administered for the remaining doses
in the vaccination
schedule to ensure protection against diphtheria
and tetanus.
top
